Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema

Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema

To predict the need for additional local corticosteroids after receiving the 0.19 mg fluocinolone acetonide (FAc) implant in patients with macular edema secondary to non-infectious uveitis previously treated with local peribulbar corticosteroids. The number of corticosteroids required prior FAc, vis...

Full description

Bibliographic Details
Main Authors: Lucy Joanne Kessler, Grzegorz Łabuz, Gerd U. Auffarth, Ramin Khoramnia
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceutics
Subjects:
uveitis
fluocinolone acetonide
macular edema
OCT biomarkers
choroidal vascularity index
Online Access:https://www.mdpi.com/1999-4923/14/4/688

Internet

https://www.mdpi.com/1999-4923/14/4/688

Similar Items